Saumitra Ray

Kolkata, WB, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications

Current status on the role of beta blocker in HFpEF: A Reappraisal.

Current status on the role of beta blocker in HFpEF: A Reappraisal.

Journal: Indian heart journal
Published: May 12, 2026

Expert Opinion on Optimising Guideline-Directed Medical Therapy and Expanding the Role of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) for Heart Failure Management in India.

Expert Opinion on Optimising Guideline-Directed Medical Therapy and Expanding the Role of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) for Heart Failure Management in India.

Journal: Cureus
Published: April 26, 2026

Hypertension Management Beyond Blood Pressure Control in India: An Expert Consensus on Angiotensin II Receptor Blocker and Calcium Channel Blocker Combination Therapy With Reference to Telmisartan and Cilnidipine.

Hypertension Management Beyond Blood Pressure Control in India: An Expert Consensus on Angiotensin II Receptor Blocker and Calcium Channel Blocker Combination Therapy With Reference to Telmisartan and Cilnidipine.

Journal: Cureus
Published: February 08, 2026

The Beta-blocker chronicle: From past principles to present practice - Implications for the Indian subcontinent.

The Beta-blocker chronicle: From past principles to present practice - Implications for the Indian subcontinent.

Journal: Indian heart journal
Published: August 21, 2025

Indian Interventional Cardiologists' Perspectives on De-escalating Dual to Single Antiplatelet Therapy in High Bleeding Risk (HBR) Patients.

Indian Interventional Cardiologists' Perspectives on De-escalating Dual to Single Antiplatelet Therapy in High Bleeding Risk (HBR) Patients.

Journal: Cureus
Published: June 30, 2025

National Consensus Statement on Role of Bisoprolol across Cardiovascular Continuum: Special Focus on Women.

National Consensus Statement on Role of Bisoprolol across Cardiovascular Continuum: Special Focus on Women.

Journal: The Journal of the Association of Physicians of India
Published: June 24, 2025

The European Society of Cardiology 2024 Guidelines on Chronic Coronary Syndromes: A Critical Appraisal.

The European Society of Cardiology 2024 Guidelines on Chronic Coronary Syndromes: A Critical Appraisal.

Journal: Journal of clinical medicine
Published: January 15, 2025

Sympathetic Overdrive and Role of Beta-blockers in Various Forms of Heart Failure: A Consensus Statement from India.

Sympathetic Overdrive and Role of Beta-blockers in Various Forms of Heart Failure: A Consensus Statement from India.

Journal: The Journal of the Association of Physicians of India
Published: November 20, 2024

Position of Beta-blockers in the Treatment of Hypertension Today: An Indian Consensus.

Position of Beta-blockers in the Treatment of Hypertension Today: An Indian Consensus.

Journal: The Journal of the Association of Physicians of India
Published: October 11, 2024

Indian Consensus on the Role and Position of Angiotensin Receptor-neprilysin Inhibitors in the Management of Heart Failure.

Indian Consensus on the Role and Position of Angiotensin Receptor-neprilysin Inhibitors in the Management of Heart Failure.

Journal: The Journal of the Association of Physicians of India
Published: September 18, 2024

Expert Opinion on the Role of Sacubitril/Valsartan in the Management of Hypertension in India.

Expert Opinion on the Role of Sacubitril/Valsartan in the Management of Hypertension in India.

Journal: Cardiology and therapy
Published: June 29, 2024

Consensus Statement from India on the Renal Benefits of ARNi, SGLT-2i, and Bisoprolol in Chronic Kidney Disease.

Consensus Statement from India on the Renal Benefits of ARNi, SGLT-2i, and Bisoprolol in Chronic Kidney Disease.

Journal: The Journal of the Association of Physicians of India
Published: June 17, 2024
Showing 1-12 of 52

Last Updated: 09/26/2026